Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OC000459 in Allergic Asthma
NCT01056692Phase 2Completed
- Sponsor
- Oxagen
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of timapiprant in allergic asthma, sponsored by Oxagen. Started Feb 2006; status: completed.
02
Drugs
timapiprant
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT01056692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01056692.